TY - JOUR
T1 - Spatial memory impairment without apoptosis induced by the combination of beta-amyloid oligomers and cerebral ischemia is related to decreased acetylcholine release in rats
AU - Watanabe, Takuya
AU - Iwasaki, Katsunori
AU - Ishikane, Shin
AU - Naitou, Tetsuya
AU - Yoshimitsu, Yoshitaka
AU - Yamagata, Norito
AU - Ozdemir, Mehmeto Bülent
AU - Takasaki, Kotaro
AU - Egashira, Nobuaki
AU - Mishima, Kenichi
AU - Fujiwara, Michihiro
N1 - Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2008
Y1 - 2008
N2 - The purpose of the present study was to examine the effect of beta-amyloid (Aβ) oligomers, not the fibrils that make up Aβ plaques, on spatial memory and the cholinergic system in rats. Recently, several researchers have suggested that small assemblies of Aβ, Aβ oligomers, caused memory loss during the early stages of Alzheimer's disease without showing cell death. In the present study, the combination of Aβ oligomers and cerebral ischemia, but not cerebral ischemia alone, significantly impaired spatial memory without apoptosis in the CA1 region of the hippocampus. Donepezil, an acetylcholinesterase inhibitor, ameliorated this memory impairment. Therefore we examined acetylcholine (ACh) release from the dorsal hippocampus. A microdialysis study showed that spontaneous release of ACh was not significantly decreased by the combination of Aβ oligomers and cerebral ischemia; however, high K+-evoked ACh release was decreased. These results suggest that a combination of Aβ oligomers and cerebral ischemia induces memory impairment by cholinergic synapse dysfunction without apoptosis. This model may be useful for developing new drugs for the treatment of early-phase Alzheimer's disease.
AB - The purpose of the present study was to examine the effect of beta-amyloid (Aβ) oligomers, not the fibrils that make up Aβ plaques, on spatial memory and the cholinergic system in rats. Recently, several researchers have suggested that small assemblies of Aβ, Aβ oligomers, caused memory loss during the early stages of Alzheimer's disease without showing cell death. In the present study, the combination of Aβ oligomers and cerebral ischemia, but not cerebral ischemia alone, significantly impaired spatial memory without apoptosis in the CA1 region of the hippocampus. Donepezil, an acetylcholinesterase inhibitor, ameliorated this memory impairment. Therefore we examined acetylcholine (ACh) release from the dorsal hippocampus. A microdialysis study showed that spontaneous release of ACh was not significantly decreased by the combination of Aβ oligomers and cerebral ischemia; however, high K+-evoked ACh release was decreased. These results suggest that a combination of Aβ oligomers and cerebral ischemia induces memory impairment by cholinergic synapse dysfunction without apoptosis. This model may be useful for developing new drugs for the treatment of early-phase Alzheimer's disease.
UR - http://www.scopus.com/inward/record.url?scp=38549122203&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38549122203&partnerID=8YFLogxK
U2 - 10.1254/jphs.FP0071648
DO - 10.1254/jphs.FP0071648
M3 - Article
C2 - 18187922
AN - SCOPUS:38549122203
SN - 1347-8613
VL - 106
SP - 84
EP - 91
JO - Journal of Pharmacological Sciences
JF - Journal of Pharmacological Sciences
IS - 1
ER -